Service Hotline +86 400-068-7188

China Cardiovascular System Drugs Industry Market Demand Forecast and Investment Strategy Planning, 2013-2017

China Cardiovascular System Drugs Industry Market Demand Forecast and Investment Strategy Planning, 2013-2017

China Cardiovascular System Drugs Industry Market Demand Forecast and Investment Strategy Planning, 2013-2017

A must-have for enterprise medium to long-term strategic planning

Without deep industry knowledge, it will be difficult to gain any return

English Version:USD7900

Including: Paper back + Electronic Copy + Invoice

Customer Hotline:+86 755 - 82925195 / 82925295

Free Hotline:+86 400-068-7188After-sales Hotline: +86 755-33013088

The Ministry of Commerce of the People's Republic of China designated Qianzhan Industrial Research Institute as the only "regional workstation for dealing with trade friction" in the Guangdong-Hong Kong-Macao Greater Bay Area

Special Statement

We are aware of that the content of our products have been stolen by some ones who changed the design and used it to deceive customers as it is their own products. Customers who are misled may experience no product received or an incomplete product. Therefore, Qianzhan Industrial Research Institute encourage you to arrange an in-person visit to our company before you make the purchase. Qianzhan has the sole copyright of all research reports. We have never had partnership or affiliated with any third party agent. Please recognize the"前瞻"trademark when purchasing reports.To have better investment return or strategic outcomes, you must have a forward-looking vision. Qianzhan Industrial Research Institute - China's leading industry consulting institutions provide you with all the things you need in business!

* The table of contents and the rest of this report are originally created by Qianzhan. Without any prior written permission, it is prohibited to copy or reproduce in any way. To have better investment return or strategic outcomes, you must have a forward-looking vision!

  • Table of Contents

  • Content Summary

China Cardiovascular System Drugs Industry Market Demand Forecast and Investment Strategy Planning, 2013-2017

Chapter 1: Overview of China Cardiovascular System Drugs Industry

1.1 Prevalence of Cardiovascular Diseases in China

1.1.1 Cardiovascular Disease and Classification

1.1.2 Patients and Death

(1) Total Patients

(2) Death Toll

1.1.3 Risks for Cardiovascular Disease

(1) High Blood Pressure

(2) Smoking

(3) Dyslipidemia

(4) Others

1.1.4 Medical Treatment for Cardiovascular Disease

1.2 Overview of Cardiovascular System Drugs Industry

1.2.1 Definition of Cardiovascular System Drugs Industry

1.2.2 Research Scope for Cardiovascular System Drugs Industry

1.2.3 Analytical Systems for Cardiovascular System Drugs Industry

Chapter 2: Development Environment for China Cardiovascular System Drugs Industry

2.1 Economic Conditions’ Impact on the Development of Industry

2.1.1 International Macro-economic Environment

(1) International Macro-economic Status

(2) International Macro-economic Outlook

2.1.2 Domestic Macro-economic Environment

(1) Domestic Macro-economic Status

(2) Domestic Macro-economic Outlook

2.1.3 Macro-economic Environment’s Impact on the Development of Industry

2.2 Social Considerations’ Impact on the Development of Industry

2.2.1 Social Considerations Associated with Cardiovascular Disease

2.2.2 Social Considerations’ Impact on the Development of Industry

2.3 Policies’ Impact on the Development of Industry

2.3.1 Explanation of Policies Related to Industry Development

2.3.2 Explanation of Regulations Related to Industry Development

2.3.3 Policies’ Impact on the Development of Industry

Chapter 3: Analysis of Market Status of Cardiovascular System Drugs Industry

3.1 Development Overview of International Cardiovascular System Drugs Market

3.1.1 Market Scale

3.1.2 Competitive Landscape

3.1.3 R&A Situation of International Pharmaceutical Corporations in China

3.1.4 Development Trend

3.2 Development Status of Domestic Cardiovascular System Drugs Industry

3.2.1 Market Features

3.2.2 Market Scale

3.2.3 Competitive Landscape in Major Cities

3.2.4 Competition Position for Major Manufacturers

Chapter 4: Analysis of Pharmaceutical Chemicals Competition for Cardiovascular System in China

4.1 Overview of Cardiovascular Pharmaceutical Chemicals Market

4.1.1 Overview of Pharmaceutical Chemicals Market

4.1.2 Size of Pharmaceutical Chemicals Market

4.1.3 Competitive Landscape for Drug Segments

4.1.4 Competitive Landscape for Regional Markets

4.2 Analysis of Cardiac drugs Market

4.2.1 Drugs and Market Overview

4.2.2 Market Size and Change Trend

4.2.3 Competitive Position for Manufacturers

4.2.4 Competitive Landscape for Drugs Market

4.2.5 Analysis of Major Drugs Market

(1) Alprostadil

(2) Phosphocreatine

(3) Coenzyme Complex

(4) Isosorbide Dinitrate

4.3 Analysis of Vasodilator Drugs Market

4.3.1 Drugs and Market Overview

4.3.2 Market Size and Change Trend

4.3.3 Competitive Position for Manufacturers

4.3.4 Competitive Landscape for Drugs Market

4.3.5 Analysis of Major Drugs Market

(1) Cinepazide

(2) Drochloride and Glucose Injection

(3) Fasudil

(4) 3-n-butylphthalide

(5) Ligustrazine

4.4 Analysis of ACE inhibitor Market

4.4.1 Drugs and Market Overview

4.4.2 Market Size and Change Trend

4.4.3 Competitive Position for Manufacturers

4.4.4 Competitive Landscape for Drugs Market

4.4.5 Analysis of Major Drugs Market

(1) Valsartan

(2) Irbesartan

(3) Losartan

(4) Telmisartan

(5) Benazepril

4.5 Analysis of Calcium Channel Blocker Market

4.5.1 Drugs and Market Overview

4.5.2 Market Size and Change Trend

4.5.3 Competitive Position for Manufacturers

4.5.4 Competitive Landscape for Drugs Market

4.5.5 Analysis of Major Drugs Market

(1) Amlodipine

(2) Nifedipine

(3) Felodipine

(4) Amlodipine

(5) Nimodipine

4.6 Analysis of Antilipemic Agents Market

4.6.1 Drugs and Market Overview

4.6.2 Market Size and Change Trend

4.6.3 Competitive Position for Manufacturers

4.6.4 Competitive Landscape for Drugs Market

4.6.5 Analysis of Major Drugs Market

(1) Atorvastatin

(2) Simvastatin

(3) Rosuvastatin

(4) Pravastatin

4.7 Analysis of Beta Blocking Agent Market

4.7.1 Drugs and Market Overview

4.7.2 Market Size and Change Trend

4.7.3 Competitive Position for Manufacturers

4.7.4 Competitive Landscape for Drugs Market

4.7.5 Analysis of Major Drugs Market

(1) Bisoprolol

(2) Metoprolol

(3) Potassium Magnesium Aspartate

(4) Esmolol

(5) Arotinolol

4.8 Analysis of Vascular Protective Agents Market

4.8.1 Drugs and Market Overview

4.8.2 Market Size and Change Trend

4.8.3 Competitive Position for Manufacturers

4.8.4 Competitive Landscape for Drugs Market

4.8.5 Analysis of Major Drugs Market

(1) Invertose

(2) Calcium Dobesilate

(3) Diosmin

(4) Troxerutin

4.9 Analysis of Antihypertensive Drug Market

4.9.1 Drugs and Market Overview

4.9.2 Market Size and Change Trend

4.9.3 Competitive Position for Manufacturers

4.9.4 Competitive Landscape for Drugs Market

4.9.5 Analysis of Major Drugs Market

(1) Urapidil

(2) Doxazosin

(3) Nitroprusside

4.10 Diuretics

4.10.1 Drugs and Market Overview

4.10.2 Market Size and Change Trend

4.10.3 Competitive Position for Manufacturers

4.10.4 Competitive Landscape for Drugs Market

4.10.5 Analysis of Major Drugs Market

(1) Torasemide

(2) Indapamide

(3) Spironolactone

(4) Furosemide

Chapter 5: Analysis of Cardiovascular System Drugs Market

5.1 Market Overview of Cardiovascular System Drug

5.2 Competitive Position for Cardiovascular System Drug Manufacturers

5.3 Competitive Landscape of Cardiovascular System Drugs

5.4 Analysis of Major Cardiovascular System Drugs

5.4.1 Ginkgo Injection

(1) Brief Introduction to the Drug

(2) Competitive Position for Major Manufactures

(3) Competitive Landscape for Regional Drugs Market

(4) Demand Trend for Drugs Market

5.4.2 Danhong Injection

(1) Brief Introduction to the Drug

(2) Competitive Position for Major Manufactures

(3) Competitive Landscape for Regional Drugs Market

(4) Demand Trend for Drugs Market

5.4.3 Danshen Ligustrazine Injection

(1) Brief Introduction to the Drug

(2) Competitive Position for Major Manufactures

(3) Competitive Landscape for Regional Drugs Market

(4) Demand Trend for Drugs Market

5.4.4 Ginkgo Biloba Tablet

(1) Brief Introduction to the Drug

(2) Competitive Position for Major Manufactures

(3) Competitive Landscape for Regional Drugs Market

(4) Demand Trend for Drugs Market

5.4.5 Carthamus Tinctorius Injection

(1) Brief Introduction to the Drug

(2) Competitive Position for Major Manufactures

(3) Competitive Landscape for Regional Drugs Market

(4) Demand Trend for Drugs Market

5.4.6 Shenmai Injection

(1) Brief Introduction to the Drug

(2) Competitive Position for Major Manufactures

(3) Competitive Landscape for Regional Drugs Market

(4) Demand Trend for Drugs Market

Chapter 6: Analysis of Leading Corporations in Cardiovascular System Drugs Industry

6.1 Overall Situation of Cardiovascular System Drugs Manufacturers

6.1.1 Comprehensive Overview of Cardiovascular System Drugs Manufacturers

6.1.2 Ranking of Cardiovascular System Drugs Manufacturers by Sales Revenue

6.1.3 Ranking of Cardiovascular System Drugs Manufacturers by Total Profits

6.2 Leading Global Cardiovascular System Drugs Brands’ Investment in China

6.2.1 Pfizer

(1) Development Overview

(2) Sales Network

(3) Product Structure

(4) Operation Situation

(5) Operation of Pfizer Dalian Plant

6.2.2 Novartis

(1) Development Overview

(2) Sales Network

(3) Product Structure

(4) Operation Situation

(5) Operation of Beijing Novartis Pharma Ltd.

6.2.3 Merck & Co., Inc.

(1) Development Overview

(2) Sales Network

(3) Product Structure

(4) Operation Situation

(5) Operation of Hangzhou Moshadong Pharmaceutical Co., Ltd.

Reporting core values

With the improvement of people’s living standard, the acceleration of population aging, and the fast pace of life, people tend to eat more high calorie food and high-fat diet food, which will easily trigger the one of the most serious diseases, named cardiovascular diseases which will threaten our health and life, such as coronary disease, hypertension, and cardiac failure.

Main Contents of report

With the improvement of people’s living standard, the acceleration of population aging, and the fast pace of life, people tend to eat more high calorie food and high-fat diet food, which will easily trigger the one of the most serious diseases, named cardiovascular diseases which will threaten our health and life, such as coronary disease, hypertension, and cardiac failure. Moreover, its morbidity and mortality rate rise year after year. Nowadays, the cardiovascular disease has become one of scariest diseases threatening people’s life in the world, whose morbidity and mortality rate jump to the top in the world. Therefore, this field is regarded as one of markets with most development potentials.

There is huge demand and prospects for cardiovascular drugs market. However, as to domestic market, a great many of market shares are occupied by leading international pharmaceutical brands or their subsidiaries, so the domestic pharmaceutical corporations need improving their R&D level and market capacity.

With Forward’s long-term tracking and collecting market data of cardiovascular system drugs industry, we roundly and accurately analyze the industry structure system for you from the view of mastering the whole industry. This report analyzes the impact of current economic, social and policy environment on the industry; moreover, from aspect of internal industry, it analyzes the market competition situation of cardiovascular pharmaceutical chemicals and traditional Chinese medicines for heart attack, and anti-hypertension in a systematic and specific way. This report will show you the competition situation of whole industry’s market with specific and objective data as well as plenty of evidence.

The most distinctive characteristics of this report is forward-looking and timeliness. Based on future development tracks and years’ practice experience of cardiovascular system drugs industry, we conduct objective and profound analysis on overall capacity, market size, competitive landscape and market demand features of China cardiovascular system drugs industry. In addition, based on future development tracks and years’ practice experience of cardiovascular system drugs industry, we conduct prudent analysis and forecast for cardiovascular system drugs industry’s future development trend. This report helps pharmaceutical corporations, R&D institutions, marketing enterprises and investment enterprises to precisely grasp current latest developments of the industry. This report is a first professional report on providing the industry with segment research for cardiovascular drugs and illustrating the competitive landscape from multiple perspectives.

Here, we would like to express our sincere gratitude to China Pharmaceutical Profession Association, Ministry of State Information Center, Bureau of Statistics of China, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council and Beijing Essence Forward Research Center, for their great support when we conduct this report!

Notice: All the market data, especially corporations' ranking data in the report, only for business reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!

Special tips: Ignoring some subtle hints in the violent change of external environment, and failure of updating strategic decisions timely will finally lead to the loss of competitive advantage. A true successful company will make scientific researches on external environment consciously or unconsciously, so as to formulate a key scientific operating strategy!

Best wishes for every enterprise with a big dream that can draw up a high-quality operating decision, to effectively avoid the risks and continuously gain the success.

Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Cardiovascular System Drugs Industry

For any special needs, please contact us.Customize Your Report

  • The National Bureau of Statistics Foreign-related investigation Permission

  • National Innovation Company and Dual Software Certified Enterprise

  • The only DRC desginated Enterprise of the Industry Yearbook

  • National Ministry of Commerce designated Industrial Early Warning and Monitoring Workstation

  • Guangdong Province Enterprise of Observing Contract and Valuing Credit

Qianzhan Industrial Research Institute· The leading company of China Business Consulting

  • 01

    Qianzhan is an industry consulting service provider with national innovation company qualification, independent research and development of industrial big data and Dual Software Certification.

  • 02

    Qianzhan is a consulting and research organization that has been engaged in business consulting for over 16 years in China.

  • 03

    Qianzhan is a consulting service provider with a team of nearly 300 industrial researchers and analysts.

  • 04

    Qianzhan is a consulting service provider with an in-house expert pool of 1200 experts.

  • 05

    Qianzhan is a research and consulting organization that have served 180000 clients and received over positive comments from 100000 of our clients.

  • 06

    Qianzhan is an industry research and consulting organization that has been designated by the highest authority, the DRC, to prepare the yearbook.

  • 07

    Qianzhan is an industry planning and consulting organization that adopts the internationally synchronized SCP scientific analysis model and the perfect industry chain research map to guide the business planning and consulting.

  • 08

    Qizhan is a consulting service organization that helps enterprises to solve the five aspects of industry research, planning, strategic design, capital operation and implementation.

What Else do We Offer

Contact Us

Shenzhen Headquarter

Free Hotline:+86 400-068-7188

Customer Hotline:+86 755 - 82925195 / 82925295

Email Address:service@qianzhan.com

3rd Floor, FIYTA Building West, High Tech South Avenue 1, Nanshan District, Shenzhen, China

Shanghai Office

Location:Rm.1106, Building 1, Jiayu International Plaza, Songhu Road, Yangpu District,
Shanghai, China